252 related articles for article (PubMed ID: 21729023)
21. Investigation of P120catenin Expression in Human Basal Cell Carcinoma of the Skin.
Bartoš V; Kullová M
Acta Medica (Hradec Kralove); 2017; 60(1):32-36. PubMed ID: 28591550
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.
Leinonen T; Pirinen R; Böhm J; Johansson R; Ropponen K; Kosma VM
Lung Cancer; 2006 Mar; 51(3):313-21. PubMed ID: 16423426
[TBL] [Abstract][Full Text] [Related]
23. [Expression of MT1-MMP and RECK protein in human gastric carcinoma].
Shen B; Zheng MQ; Xu XY; Mo FG; Zhang T; Feng JF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):364-7. PubMed ID: 22338226
[TBL] [Abstract][Full Text] [Related]
24. Possible role of matrix metalloproteinases (MMPs) in hyperostosis of intracranial meningiomas.
Pei J; Jung S; Jin SG; Moon KS; Wen M; Li SY; Jang WY; Ryu HH; Lee KH; Kim IY; Jung TY
Acta Neurochir (Wien); 2012 Apr; 154(4):611-20; discussion 620. PubMed ID: 22327326
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis.
Ueda M; Yamashita Y; Takehara M; Terai Y; Kumagai K; Ueki K; Kanda K; Hung YC; Ueki M
Gynecol Endocrinol; 2002 Oct; 16(5):391-402. PubMed ID: 12587534
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
27. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of PHLDA1 (TDAG51) in basal cell carcinoma and trichoepithelioma.
Yeh I; McCalmont TH; LeBoit PE
Br J Dermatol; 2012 Nov; 167(5):1106-10. PubMed ID: 22958125
[TBL] [Abstract][Full Text] [Related]
29. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
Polette M; Gilles C; Nawrocki-Raby B; Lohi J; Hunziker W; Foidart JM; Birembaut P
Cancer Res; 2005 Sep; 65(17):7691-8. PubMed ID: 16140936
[TBL] [Abstract][Full Text] [Related]
30. Role of cyclooxygenase-2, ezrin and matrix metalloproteinase-9 as predictive markers for recurrence of basal cell carcinoma.
El-Khalawany MA; Abou-Bakr AA
J Cancer Res Ther; 2013; 9(4):613-7. PubMed ID: 24518705
[TBL] [Abstract][Full Text] [Related]
31. Nodular basal cell carcinoma is associated with increased hyaluronan homeostasis.
Tzellos TG; Kyrgidis A; Vahtsevanos K; Triaridis S; Printza A; Klagas I; Zvintzou E; Kritis A; Karakiulakis G; Papakonstantinou E
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):679-87. PubMed ID: 20849445
[TBL] [Abstract][Full Text] [Related]
32. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
34. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
35. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma.
Ansarin H; Daliri M; Soltani-Arabshahi R
Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma.
Kikuchi R; Noguchi T; Takeno S; Kubo N; Uchida Y
Br J Cancer; 2000 Jul; 83(2):215-8. PubMed ID: 10901373
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
Docampo MJ; Cabrera J; Rabanal RM; Bassols A
Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
[TBL] [Abstract][Full Text] [Related]
40. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
